Prostatic Neoplasms Completed Phase 3 Trials for Meloxicam (DB00814)

Also known as: Neoplasm,Prostatic / Neoplasms, Prostatic / Prostatic Neoplasm

IndicationStatusPhase
DBCOND0028225 (Prostatic Neoplasms)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00152919Mobicox: Study of Meloxicam to Reduce Prostate Swelling in Permanent Seed Prostate BrachytherapyTreatment